Jia Jie Biomedical Co., Ltd. (TPEX:4109)
Taiwan
· Delayed Price · Currency is TWD 12.80
+0.05 (0.39%)
Mar 10, 2026, 12:04 PM CST
Jia Jie Biomedical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,514 | 2,202 | 1,530 | 1,307 | 1,192 | 1,224 | Upgrade
|
| Market Cap Growth | -33.77% | 43.94% | 17.01% | 9.70% | -2.60% | -12.13% | Upgrade
|
| Enterprise Value | 1,036 | 1,973 | 1,318 | 1,080 | 900 | 1,174 | Upgrade
|
| Last Close Price | 12.75 | 21.06 | 15.99 | 13.66 | 12.46 | 16.50 | Upgrade
|
| PE Ratio | 465.10 | 10.42 | 10.61 | - | 223.17 | - | Upgrade
|
| PS Ratio | 3.14 | 4.10 | 4.60 | 4.12 | 4.92 | 4.53 | Upgrade
|
| PB Ratio | 0.90 | 1.62 | 1.43 | 1.42 | 1.27 | 1.35 | Upgrade
|
| P/TBV Ratio | 0.96 | 1.75 | 1.49 | 1.49 | 1.34 | 1.35 | Upgrade
|
| P/FCF Ratio | - | 89.07 | - | - | 417.57 | 48.05 | Upgrade
|
| P/OCF Ratio | 49.24 | 49.65 | - | - | 272.52 | 45.15 | Upgrade
|
| EV/Sales Ratio | 2.15 | 3.68 | 3.96 | 3.40 | 3.71 | 4.34 | Upgrade
|
| EV/EBITDA Ratio | 26.94 | 42.68 | - | - | 89.57 | - | Upgrade
|
| EV/EBIT Ratio | 48.45 | 59.50 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | -23.97 | 79.83 | - | - | 315.32 | 46.08 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.23 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.22 | 0.17 | - | 2.76 | 0.53 | - | Upgrade
|
| Debt / FCF Ratio | - | 0.34 | - | - | 2.32 | 0.16 | Upgrade
|
| Net Debt / Equity Ratio | -0.30 | -0.19 | -0.13 | -0.26 | -0.30 | -0.37 | Upgrade
|
| Net Debt / EBITDA Ratio | -14.15 | -5.51 | 2.59 | 426.00 | -27.84 | 9.40 | Upgrade
|
| Net Debt / FCF Ratio | 11.72 | -10.30 | 10.71 | 9.20 | -98.00 | -13.35 | Upgrade
|
| Asset Turnover | 0.29 | 0.37 | 0.28 | 0.31 | 0.24 | 0.29 | Upgrade
|
| Inventory Turnover | 12.41 | 14.79 | 8.38 | 8.48 | 8.86 | 6.63 | Upgrade
|
| Quick Ratio | 3.71 | 2.68 | 1.20 | 3.71 | 3.79 | 4.55 | Upgrade
|
| Current Ratio | 3.93 | 2.98 | 1.30 | 4.32 | 4.15 | 4.79 | Upgrade
|
| Return on Equity (ROE) | 0.42% | 17.79% | 14.74% | -0.69% | 0.55% | -4.08% | Upgrade
|
| Return on Assets (ROA) | 0.80% | 1.43% | -3.42% | -0.84% | -0.06% | -3.27% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.53% | 3.13% | -8.23% | -2.05% | -0.15% | -7.77% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.30% | 2.40% | -6.20% | -1.50% | -0.10% | -5.30% | Upgrade
|
| Earnings Yield | 0.22% | 9.60% | 9.42% | -0.42% | 0.45% | -2.61% | Upgrade
|
| FCF Yield | -2.86% | 1.12% | -0.86% | -2.04% | 0.24% | 2.08% | Upgrade
|
| Dividend Yield | 3.76% | 2.37% | 3.13% | - | - | - | Upgrade
|
| Payout Ratio | - | 23.36% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -16.11% | -10.08% | -0.29% | - | -28.10% | -0.71% | Upgrade
|
| Total Shareholder Return | -12.35% | -7.71% | 2.84% | - | -28.10% | -0.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.